Biotech - Spark Newswire

1 minute read

Orthofix To Present At JMP Securities Life Sciences Conference Jun. 16

June 11, 7:06 AM

Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that President and Chief Executive Officer Jon Serbousek and Chief Financial Officer Doug Rice will

OFIX

4 minute read

FDA
News

Forma Therapeutics Highlights Presentation Of New Phase 1 Data On Etavopivat At European Hematology Association Congress

By Benzinga Newsdesk

June 11, 7:05 AM

Clinical results demonstrated durable improvement in hematologic and hemolytic markers, supporting the potential for improvement of red blood cell functional health in those with sickle cell disease Initial results from

FMTX

2 minute read

Autolus Therapeutics Highlights Presentation Of AUTO1 Data At European Hematology Association Virtual Congress 2021

By Bill Haddad

June 11, 7:05 AM

Autolus Therapeutics plc (NASDAQ:AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced a poster presentation related to AUTO1 (obecabtagene

AUTL

1 minute read

Protagonist Therapeutics Highlights Presentation Of Phase 2 Rusfertide Data At European Hematology Association 2021 Virtual Congress.

By Bill Haddad

June 11, 7:04 AM

Protagonist Therapeutics (NASDAQ:PTGX) ("Protagonist" or "the Company") today announced updated results from the ongoing Phase 2 study of rusfertide, an investigational new drug being evaluated

PTGX

4 minute read

FDA
News

Equillium Reports Topline Results From EQUATE Study In First-Line Treatment Of Acute Graft-Versus-Host Disease

By Benzinga Newsdesk

June 11, 7:03 AM

Itolizumab continues to demonstrate favorable safety and efficacy profile Rapid and durable responses resulted in clinically meaningful reduction in corticosteroid use Data support clinical advancement of itolizumab in

5 minute read

Curis Highlights Presentation Of Data From Ongoing Phase 1/2 Study Of CA-4948 At European Hematology Association 2021 Virtual Congress

By Bill Haddad

June 11, 7:03 AM

Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced updated data from its ongoing Phase 1/2 open-label, single arm, dose

CRIS

1 minute read

Precigen Stock Surges On Positive AG019 Data for Chronic Treatment Of Type 1 Diabetes

By Vandana Singh

June 11, 6:58 AM

Precigen Inc’s (NASDAQ:PGEN) subsidiary Precigen ActoBio announced topline results from the Phase 1b/2a study evaluating AG019 ActoBiotics to treat recent-onset type…

PGEN

1 minute read

European Medicines Agency Gives Update On Evaluation Of COVID-19 Vaccine Plus Myocarditis, Pericarditis Cases: Notes Cases Of Myocarditis And/Or Pericarditis Were Also Reported In Europe Following Vaccination With All COVID-19 Vaccines

By Benzinga Newsdesk

June 11, 6:52 AM

-Reuters

BNTX

1 minute read

FDA
News

Brazilian Health Regulator, Anvisa, Approves Use Of Pfizer COVID-19 Vaccine For Children 12+

By Benzinga Newsdesk

June 11, 6:41 AM

-Reuters

EWZ

3 minute read

FDA
News

Novan Reports Topline Results From Pivotal Phase 3 Trial Of SB206 In Patients With Molluscum Contagiosum: Achieves Statistical Significance, No Serious Adverse Events Reported

By Benzinga Newsdesk

June 11, 6:32 AM

– B-SIMPLE4 achieves statistical significance for the primary endpoint with p-value less than 0.0001 – – No serious adverse events related to treatment with SB206 – – Novan intends to

NOVN